The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Ascentage Pharma; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Janssen-Cilag; Loxo/Lilly; Roche/Genentech; TG Therapeutics
Consulting or Advisory Role - Ascentage Pharma; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Janssen-Cilag; Loxo/Lilly; Merck; Roche/Genentech (Inst); TG Therapeutics
Research Funding - Abbvie; Bristol-Myers Squibb; Merck (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Roche
Updated results of the selective Bruton tyrosine kinase (BTK) inhibitor TG-1701, as monotherapy and in combination with ublituximab and umbralisib (U2) in patients (pts) with B-cell malignancies.
 
Chan Cheah
No Relationships to Disclose
 
Wojciech Jurczak
Consulting or Advisory Role - AstraZeneca; BeiGene; Debiopharm Group; Loxo; MEI Pharma; Takeda
Research Funding - Acerta Pharma; AstraZeneca; BeiGene; Debiopharm Group; Genentech; GlaxoSmithKline; Incyte; Janssen; Loxo; MEI Pharma; MorphoSys; Nordic Nanovector; Takeda; TG Therapeutics
 
Masa Lasica
Research Funding - TG Therapeutics
 
Nicholas W. Wickham
Research Funding - TG Therapeutics
 
Tomasz Wrobel
Honoraria - Amgen; Celgene; Gilead Sciences; Janssen-Cilag; Roche
Consulting or Advisory Role - Abbvie; Amgen; Janssen-Cilag; Novartis; Roche/Genentech; Takeda
Research Funding - Roche
 
Jan Andrzej Walewski
Honoraria - Abbvie; Amgen; Gilead Sciences; Novartis; Roche; Servier; Takeda
Consulting or Advisory Role - Abbvie; Gilead Sciences; Novartis; Roche; Takeda/Millennium
Travel, Accommodations, Expenses - Roche
 
Costas K. Yannakou
Research Funding - TG Therapeutics
 
Stanley Cheung
Consulting or Advisory Role - Novartis
 
Katharine L. Lewis
Honoraria - Janssen; Roche
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Janssen; Novartis
 
Monika Długosz-Danecka
Consulting or Advisory Role - Abbvie; SERVIER
Speakers' Bureau - Janssen; Roche; SERVIER; Takeda
Research Funding - MacroGenics; TG Therapeutics
 
Krzysztof Giannopoulos
Honoraria - Amgen; Bristol-Myers Squibb/Celgene; Janssen; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Sanofi; Takeda
Research Funding - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Sanofi; Takeda; TG Therapeutics
 
Hari P. Miskin
Employment - TG Therapeutics
Leadership - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
Travel, Accommodations, Expenses - TG Therapeutics
 
Jian-Ping Tang
Employment - TG Therapeutics
Stock and Other Ownership Interests - Alexion Pharmaceuticals; Roche; TG Therapeutics
 
Emmanuel Normant
Employment - TG Therapeutics
Stock and Other Ownership Interests - Surface Oncology; TG Therapeutics
 
Owen A. O'Connor
Employment - TG Therapeutics
Leadership - Kymera; NomoCan; TG Therapeutics
Stock and Other Ownership Interests - Kymera; TG Therapeutics
Honoraria - Astex Pharmaceuticals; Celgene; Kymera
Consulting or Advisory Role - Celgene; Kymera; Mundipharma; SERVIER
Research Funding - Astex Pharmaceuticals; Celgene; Merck
 
Alejandro Daniel Ricart
Employment - TG Therapeutics
Leadership - TG Therapeutics
Stock and Other Ownership Interests - Collegium; Immunomedics; Merck; Pfizer; Seagen; Stemline Therapeutics; TG Therapeutics
 
Constantine Si Lun Tam
Honoraria - Abbvie; Beigene; Janssen-Cilag; Novartis; Pharmacyclics
Consulting or Advisory Role - Abbvie; BeiGene; Janssen; Loxo; Roche
Research Funding - Abbvie (Inst); Janssen-Cilag (Inst)